Vimarsana
Biggest News Aggregation in the World

Page 19 - Technologies Munich News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technologies Munich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technologies Munich Today - Breaking & Trending Today

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions - Vimarsana News

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions - read this article along with other careers information, tips and advice on BioSpace

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions - Vimarsana News

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

ITM and ANSTO Announce Extension of Licensing Agreement for the Production and Supply of the Medical Radioisotope n.c.a. Lutetium-177 - Vimarsana News

ITM and ANSTO Announce Extension of Licensing Agreement for the Production and Supply of the Medical Radioisotope n.c.a. Lutetium-177

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
ITM Isotope Technologies Munich SE: ITM and ANSTO Announce Extension of Licensing Agreement for the Production and Supply of the Medical Radioisotope n.c.a. Lutetium-177 - Vimarsana News

ITM Isotope Technologies Munich SE: ITM and ANSTO Announce Extension of Licensing Agreement for the Production and Supply of the Medical Radioisotope n.c.a. Lutetium-177

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, and the Australian Nuclear Science and Technology Organisation (ANSTO), a public research organization and international

ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therap - Vimarsana News

ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therap

  Companies will work toward accessing a novel strategy for breaking the tumor microenvironment by combining ITM’s high-quality radioisotopes with Navigo’s precise target-specific affinity ligands against the fibroblast activation protein (FAP)GARCHING/MUNICH, Germany and HALLE/SAALE, Germany, December 02,...